Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-4,260
Closed -$261K 131
2017
Q2
$261K Sell
4,260
-247
-5% -$15K 0.06% 123
2017
Q1
$273K Buy
4,507
+394
+10% +$23.9K 0.06% 121
2016
Q4
$231K Buy
4,113
+156
+4% +$9.13K 0.05% 133
2016
Q3
$236K Buy
3,957
+134
+4% +$7.84K 0.06% 127
2016
Q2
$210K Buy
+3,823
New +$203K 0.05% 132
2015
Q3
Sell
-4,138
Closed -$225K 143
2015
Q2
$225K Buy
4,138
+313
+8% +$17.6K 0.05% 130
2015
Q1
$210K Hold
3,825
0.05% 124
2014
Q4
$207K Hold
3,825
0.05% 127
2014
Q3
$216K Buy
3,825
+61
+2% +$3.42K 0.05% 125
2014
Q2
$208K Sell
3,764
-6
-0.2% -$327 0.05% 122
2014
Q1
$204K Buy
+3,770
New +$195K 0.05% 118
2013
Q3
Sell
-3,878
Closed -$172K 272
2013
Q2
$172K Buy
+3,878
New +$173K 0.05% 109

Other funds holding MRK

Cobiz Wealth's MRK Position: Q3 2017 in Review

Cobiz Wealth sold out of Merck (MRK) in Q3 2017, closing a stake of 4,260 shares — an estimated $261K sold.

Cobiz Wealth first reported a position in MRK in Q2 2013 and held it in 12 quarters. The position peaked at $273K in Q1 2017. 1,923 funds tracked by Wall St. Rank hold MRK as of Q3 2017.

  • Cobiz Wealth reported no remaining Merck position as of Q3 2017 after selling out during the quarter.
  • Cobiz Wealth sold 4,260 Merck shares in Q3 2017, an estimated $261K.
  • Cobiz Wealth first reported a position in Merck in Q2 2013 and held it in 12 quarters.
  • Cobiz Wealth's Merck position peaked at $273K in Q1 2017.
  • 1,923 funds tracked by Wall St. Rank held Merck as of Q3 2017.

Based on Cobiz Wealth's 13F filing for Q3 2017, filed 16 Oct 2017.